Karyopharm's drug reduces spleen size in rare blood cancer study

March 24 (Reuters) - Karyopharm Therapeutics said on Tuesday its therapy for patients with a rare blood cancer showed a ...

Karyopharm's drug meets one of two goals in blood cancer trial

By Puyaan Singh and Sahil Pandey March 24 (Reuters) - Karyopharm Therapeutics said on Tuesday its therapy led to significant reduction in spleen size in a late-stage study of patients with a rare ...
Cancer Therapy Advisor

Selinexor Combo Hits Spleen Target, Misses Symptom Endpoint in Myelofibrosis

Results from the phase 3 SENTRY trial show that selinexor plus ruxolitinib significantly reduced spleen volume in patients with myelofibrosis.
Healio

Incidentally detected splenomegaly may be risk factor for blood, liver cancers

Please provide your email address to receive an email when new articles are posted on . Individuals in the highest percentiles of spleen size may have an increased risk for developing hematologic ...
Nanowerk

AI model uses 3D lipid structures to improve mRNA nanoparticle delivery

An AI model that screens ionizable lipids by 3D conformation identified a candidate 14.8 times more efficient than current ...